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ABSTRACT
Background: In order to attenuate the measurement error inherent in dietary recall
methods, alkylresorcinols (ARs) have been proposed as a biomarker of whole-grain
(WG) intake (1, 2). Although ARs have shown promise in experimental (3) and
observational studies (4), most of this research has been conducted in Nordic
populations that consume relatively high amounts of WG (5).
Objectives: The objectives of this study were to assess the utility of plasma AR
concentration as a WG intake biomarker and identify the primary dietary and nondietary determinants of plasma AR concentration in a population that consumes
relatively few WG.
Methods: This ancillary study used data from first-year college students (n=122) who
completed three interviewer-administered 24-hour recalls and had two fasting venous
blood draws performed on non-consecutive days. Dietary data was compiled using the
Nutrition Data System for Research (6). Blood lipids and glucose were determined via
enzymatic assay and plasma AR concentrations were determined by gas
chromatography-mass spectrometry (7). Correlation coefficients (rs) were calculated
between plasma AR concentrations and dietary intake variables and cardiometabolic
risk factors. One-way ANOVA and Tukey’s post-hoc test were used to assess group
differences across plasma AR quartiles. Determinants of plasma AR concentration
were assessed using multiple regression models. Statistical analyses were performed
using R version 3.2.3.
Results: Plasma AR concentration was significantly positively correlated with WG
intake (rs = 0.24, p <0.01). The correlation was stronger in males (n=36, rs = 0.33, p <

0.05) than females (n=86, rs = 0.18, p = 0.08). One-way ANOVA across plasma AR
quartiles was significant for fiber intake [F(3,118) = 8.58, p < 0.001] and Tukey’s
HSD test showed that the mean daily fiber intake for the highest AR quartile was
significantly greater than for the lowest (M = 20.2 ± 1.9 g, 14.7 ± 1.4 g respectively).
The only cardiometabolic risk factor that was significantly associated with plasma AR
concentration was triglycerides (rs = 0.27, p < 0.01). Multiple regression models
including log-transformed dietary variables showed that WG bread was the only
significant food-item predictor of plasma AR concentration (β = 0.54, p < 0.01).
Conclusions: Although plasma AR concentration was significantly associated with
WG and fiber intake, triglycerides were the primary determinant and the relationships
were not strong enough to produce accurate WG intake prediction models. More
research is needed on the use of AR as a quantitative biomarker in low WGconsuming populations.
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MANUSCRIPT
INTRODUCTION
Although the inverse association between whole-grain (WG) intake and
chronic disease risk is well-established (1-3), a number of challenges still exist in
assessing WG intake. These include systematic and random measurement errors
inherent in dietary reporting tools (4, 5), and consumer confusion in identifying WG
products and evaluating serving sizes (6, 7). To deal with these challenges and
improve the detection of relationships between WG intake and disease,
alkylresorcinols (ARs) have been proposed as an objective biomarker of WG intake
(8-10).
Alkylresorcinols are phenolic lipids consumed almost exclusively from wheat
and rye bran (11), and are absorbed and metabolized after consumption with a plasma
half-life of ~5h (8, 12, 13). Intervention (14-18) and free-living (9, 19-22) studies have
shown that plasma AR concentration is a valid, dose-responsive biomarker of WG
intake and has moderate reproducibility up to 4 months. Correlation coefficients range
from 0.24 – 0.56 for the relationship between plasma AR and total WG, WG wheat,
WG rye and fiber intakes. The correlation between plasma AR and WG intake may be
stronger in groups that consume more WG. This was shown with both acute
consumption in a controlled feeding trial (14) and habitual consumption in
observational and long-term intervention studies (16, 20). Many of the studies testing
AR as a WG intake biomarker have been done in Nordic populations (9, 17, 19-21, 23,
24) which have relatively high habitual WG intake and consume more rye-based WG
which has a higher AR content by weight than wheat (25, 26).
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Few studies have tested plasma AR as a WG intake biomarker in American
populations which consume relatively few WG, and those WG are primarily from
wheat (27). To be a universally valid WG intake biomarker, plasma AR concentration
should also reflect WG intake in populations that consume few WG from primarily
non-rye sources. In this study, we examined the relationship between plasma AR
concentrations and self-reported WG intake in a group of free-living first year
American college students who consumed relatively few WG. Our objectives were to
assess the utility of plasma AR concentration as a WG intake biomarker and to
identify the primary dietary and non-dietary determinants of plasma AR concentration
in this population.
MATERIALS AND METHODS
This ancillary study was completed using blood samples and data from a crosssectional study done at the University of Rhode Island with first-year college students
from spring 2008 through fall 2009. A subset of 130 students was randomly selected
from the original study sample. Students between 18 and 24 years of age were eligible
for the original study. Exclusion criteria included being pregnant or lactating, or selfreport of one of the following conditions: eating disorder, liver disease, bleeding
disorder, diabetes, cancer, or CHD. Both the original and ancillary studies were
approved by the University of Rhode Island Institutional Review Board.
Anthropometric measures:
All measurements were performed by trained study staff using standardized
protocols. Measurements were performed in duplicate. Additional measures were
performed if the variance in duplicate measures was outside pre-established standards.
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Averages of repeated measures with acceptable variances were reported. Height was
measured to the nearest 0.1 cm using a Seca 220 stadiometer. Weight was measured to
the nearest 0.1 kg using a calibrated digital Seca 760 Scale. Body mass index was
calculated as weight in kg/height in meters2. Waist circumference was measured to the
nearest 0.1 cm at the top of the iliac crest using a Gulick fiberglass, non-stretchable
tape measure (Patterson Medical Products).
Biochemical measures:
A trained phlebotomist completed two 12-hour fasting venous blood draws on
two non-consecutive mornings in the same week. Plasma was obtained via
centrifugation of whole blood for 20 minutes at 2200 RPM at 4°C. A preservation
cocktail was added to the plasma containing: 0.01g/100g phenylmethylsulfonyl
fluoride (Roche), 0.01g/100g sodium azide (Fisher) and 0.05g/100g aprotinin (Fisher).
Samples were stored in a -80°C freezer until analysis.
Enzymatic assays were performed to determine TC, HDL-C, TAG and glucose
concentrations. A Roche diagnostic Chol kit was used to measure TC concentrations
(28). A Roche/Hitachi Chol kit was used to measure HDL-C after apo-B containing
lipoproteins were precipitated using dextran sulfate and magnesium chloride (Acros
Organics) (29). A Roche/Hitachi Trig/GB (Roche) kit was used to measure TAG
concentrations (30). The Friedewald equation was used to calculate LDL-C
concentrations (31). An Autokit Glucose kit (Wako Diagnostics) was used to measure
glucose concentrations. Plates were read in a Biotek ELX 808 plate reader.
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Blood pressure was measured by a trained exercise physiologist after a fiveminute seated resting period using a Littman Select stethoscope and a Welch-Allyn
blood pressure cuff. Measures were taken in duplicate with one minute between
measurements. If systolic or diastolic values varied by greater than 2 mmHg then the
measurement was repeated.
Plasma samples were shipped to the Swedish University of Agricultural
Science in Uppsala, Sweden for AR quantification as previously described (32).
Briefly, samples were incubated at 37°C with an internal standard. Plasma proteins
were precipitated to release bound AR and the organic phase was extracted using
diethyl ether. Samples were then cleaned using Oasis MAX cartridges (Waters
Corporation). Gas chromatography-mass spectrometry analysis was then performed on
a TR-5 column using a Finnigan Trace GC Ultra Gas chromatograph coupled to a
Finnigan Trace DSQ II mass detector. Homologues C17:0 to C25:0 were quantified
using molecular ions. Minimum and maximum quantification concentrations were 7
and 870 nmol/L.
Dietary measures:
Each participant completed three 24-hour recalls administered by trained staff
using the multiple pass method in conjunction with the Nutrition Data System for
Research (NDS-R) software versions 2007 and 2008 (University of Minnesota) (33).
The first recall was completed in person and two over the phone on non-consecutive
days including two weekdays and one weekend day (34). NASCO food models
(NASCO) were available during the first 24-hour recall to help visualize and estimate
portion sizes. Food booklets designed by the Nutrition Coordinating Center at the
4

University of Minnesota were also provided to participants to help with portion size
estimation.
Statistical analyses:
Data are represented as means ± SD unless stated otherwise. Non-normal
variables were log-transformed before analysis to reduce skewness. Independent
samples t-tests were performed to test for differences between genders in relevant
dietary and biochemical measures using a Bonferroni correction for multiple
comparisons. Spearman’s rs were calculated to assess the correlation between plasma
AR concentration and dietary and biochemical measures. Spearman’s rs were also used
to assess correlation between individual AR homologue concentrations and WG intake
measures (total WG, WG cereal, WG bread, fiber). Univariate and multivariate
regression models were used to determine the dietary and non-dietary determinants of
plasma AR concentrations. In all analyses, dietary intake variables were means of
three 24-hour recalls. Analyses were performed using R version 3.2.3.
RESULTS
Participant characteristics:
The mean participant age was 18.3±0.5 y and 70% (n=86) were females (Table
2). The average BMI was 23.4±3.8; 23% of participants were overweight and 6.5%
were obese. The majority of participants (62.3%) did not show any metabolic
syndrome criteria (35) and only 3 participants showed 3 or more criteria (Table 1).
The most common metabolic syndrome criteria was low HDL-C (19.6%) followed by
elevated TAG (13.1%) and elevated blood glucose (11.5%).
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WG intake and plasma AR concentration:
The mean daily intake of WG was 1.59±1.86 oz servings and the mean daily
fiber intake was 16.9±8.6 g. Twenty-one participants reported consuming no WG. The
primary dietary sources of WG were breads and cereals, which accounted for 70.0% of
WG intake (Figure 1). Males consumed 23% more fiber than females (19.6±8.6 g,
15.9±7.2 g, p=0.01) and 33% more WG (1.95±2.71 oz, 1.45±1.35 oz, p=0.09). The
mean plasma AR concentration was 61.6±71.0 nmol/L and there was no significant
difference between males and females (59.9±76.1 nmol/L, 62.3±69.3 nmol/L). C17:0
was the predominant AR homologue and the mean C17:0:C21:0 ratio was 0.12±0.09
indicating that participants consumed wheat as their primary WG (18) (Figure 2).
WG intake and plasma AR concentration:
The correlation between WG intake and total plasma AR concentration was
significant and positive (rs = 0.24, p < 0.01). A significant positive correlation between
fiber intake and total plasma AR concentration was also observed (rs = 0.27, p < 0.01)
(Table 3). All plasma AR homologue concentrations were significantly correlated with
WG intake (rs = 0.20 – 0.25) and with fiber intake (rs = 0.20 – 0.32). Total plasma AR
concentration was significantly correlated with WG bread intake (rs = 0.27, p <0.01)
and WG cereal intake (rs = 0.20, p < 0.05). The only WG intake category that did not
include wheat or rye was popcorn, which was not significantly correlated with total
plasma AR concentration (rs = -0.11, p = 0.24). One-way ANOVA results showed that
the highest quartile of AR concentration had significantly higher WG and fiber intake
than the lowest quartile.
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When examining associations by gender, males showed stronger correlations
between WG intake measures and plasma AR concentrations. The correlation between
total WG intake and total plasma AR was significant for males (rs = 0.33, p > 0.05),
but not for females (rs = 0.18, p = 0.11) (Table 3). All plasma AR homologue
concentrations were significantly correlated with total WG intake in males (rs = 0.30 –
0.38) while none were significantly correlated in females (rs = 0.10 – 0.19) (Figure 3).
All plasma AR homologue concentrations were also significantly correlated with WG
bread intake in males (rs = 0.35 – 0.44) while only C19:0 and C21:0 were significantly
correlated in females (rs = 0.26, 0.21 respectively).
Classification of subjects into the same or adjacent WG intake quartile based
on total plasma AR quartile ranged from 58% to 78% across quartiles (Table 4). The
gross misclassification rate, defined as subjects in the first or fourth WG quartile being
classified in the opposite AR quartile, was 9.7% to 13.8%. Cohen’s weighted κ for
agreement was 0.15 indicating slight agreement between quartile classification.
Associations with cardiometabolic risk factors
The only metabolic syndrome criteria that was significantly associated with
total plasma AR concentration was TAG (rs = 0.27, p < 0.01). One-way ANOVA
results showed that the highest quartile of plasma AR concentration had significantly
higher TAG concentrations than the lowest quartile (Table 4). WG intake was only
significantly correlated with HDL (rs = 0.20, p > 0.05). Neither WG intake nor total
plasma AR concentration was significantly associated with BMI.
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DISCUSSION
This study was one of the first to assess plasma AR concentration as a WG
intake biomarker in a low-WG consuming Western population. The mean WG intake
in this study was 1.51±1.81 oz servings per day (Figure 1). Although this is higher
than the American average of 0.97 oz servings per day (36), it is lower than reported
intakes in Nordic countries where most AR studies have been conducted. Nordic
population-based studies have reported average intakes of at least 2 oz servings per
day and observational studies investigating ARs in Nordic populations have reported
average intakes of 4-8 oz servings per day (19, 23, 25, 37).
The mean total plasma AR concentration in this sample was 61.6±71.0 nmol/L.
This is lower than averages from many observational studies in Nordic populations
which ranged from 66-115 nmol/L (19, 20, 37). Additionally, the mean plasma C17:0
concentration in this sample was 2.35±3.51 nmol/L, while averages from Nordic
samples ranged from 5-10.5 nmol/L (9, 20). The C17:0 homologue is more prevalent
in rye bran compared to wheat (17, 18), indicating lower rye consumption in this
sample. This observation is consistent with previous work showing higher rye intake
in Nordic compared to Western populations (25).
Despite relatively low intake, WG and fiber intake were significantly
positively correlated with total plasma AR concentration (rs = 0.24, 0.28 respectively)
(Table 3, 4), and with all individual homologues (rs = 0.20-0.32) (Table 4). These
correlation coefficients are consistent with some studies done in Nordic populations (rs
= 0.24-0.25) (19, 23) and slightly lower than others (rs = 0.41-0.57) (20, 21). When
examined by gender these correlations were all significant in males (total AR rs =
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0.33, homologues rs = 0.30-0.38) and all non-significant in females (total AR rs = 0.18,
homologues rs = 0.10-0.19) (Table 4).
There are potential physiologic and non-physiologic explanations for the
observed gender-specific differences in WG-AR correlations. First, previous research
has shown that females tend to under-report dietary intake to a greater extent than men
(38, 39). Gender differences in lipid metabolism may also explain the differences in
correlations (40). Plasma ARs are transported in the blood in lipoproteins, primarily
very low density lipoprotein (VLDL) (18). Plasma TAG concentration can act as a
direct estimator of VLDL concentration (41) and in this sample women had
significantly higher plasma TAG concentrations. This indicates that women may have
had higher VLDL concentrations leading to more efficient transport and metabolism
of ARs. Women also metabolize ϒ-tocopherol, a proposed model molecule for AR
metabolism (37, 42, 43), more efficiently (44) which may further explain these
differences. Tocopherols are also transported in VLDL particles (45), but whether
gender differences in metabolism are due to general differences in lipid metabolism or
differences in activity and expression of tocopherol-specific enzymes remains to be
determined (44).
The primary sources of WG intake in this sample were bread and cereal, which
accounted for 70% of total WG intake (Figure 1). Multivariate regression models
predicting total AR and homologue concentrations that included whole- and refinedgrain bread and cereal explained 6-13% of the variation in AR concentrations (Table
6). These models identified WG bread as the major food-item determinant of plasma
AR concentrations. In models including dietary and non-dietary variables, TAG was
9

shown to be the primary determinant or plasma AR concentrations. The positive
correlation between total AR and TAG was significant (rs = 0.27) and predictive
models including TAG achieved R2 values approaching 0.20 while models including
only dietary variables did not surpass R2 = 0.14.
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CONCLUSION
In conclusion, the results of this study demonstrate that plasma AR
concentrations are positively correlated with WG intake in a low WG-consuming
population. The relationship between WG intake and AR concentrations was stronger
in males than females which could be due to a number of physiologic or nonphysiologic reasons. The primary dietary determinant of AR concentrations was WG
bread and models including only dietary variables explained about 14% of the
variation in AR concentrations. Plasma TAG was the strongest non-dietary
determinant of AR concentrations and had the highest predictive power in regression
models. Models including TAG and dietary variables explained about 20% of the
variation in AR concentrations. Although there was a notable linear relationship
between WG intake and AR concentrations, the relationship was not strong enough to
produce good predictive WG intake models. This study’s findings of correlations
coefficients rs = 0.20-0.40 and R2 values of 0.15-0.20 are consistent with findings from
Nordic populations that consume more WG. This suggests that plasma ARs function
equally well across a range of WG intakes.
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TABLES AND FIGURES
Table 1: Demographics, biochemical and dietary descriptives
Total (n=122)

Males (n=36)

Females (n=86)

Age (y)

18.3±0.5

18.3±0.5

18.3±0.5

BMI (kg/m2)

23.4±3.8

24.0±3.4

23.2±4.0

Total cholesterol (mg/dL)

147.8±28.7

134.6±19.8

153.4±30.0

Triglycerides (mg/dL)

89.0±50.5

74.8±43.0

95.0±52.5

HDL-C (mg/dL)

58.4±14.6

51.8±9.8

61.1±15.4

LDL-C (mg/dL)

71.7±26.2

67.9±21.0

73.2±28.0

Blood glucose (mg/dL)

89.2±9.0

90.2±8.4

88.8±9.3

Total plasma AR (nmol/L)

61.6±71.0

59.9±76.1

62.3±69.3

WG intake (oz servings/day)

1.59±1.86

1.95±2.71

1.45±1.35

Total dietary fiber (g/day)

16.9±8.6

19.6±10.9

15.9±7.2

Values are means ± standard deviation, BMI, body mass index; LDL-C, low-density
lipoprotein cholesterol; AR, alkylresorcinol; WG, whole-grain
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Table 2: Metabolic syndrome characteristics
Number of
MetS criteria

n (%)

MetS criteria

n (%)
9 (7.4)

0

76 (62.3)

Waist Circumference

1

32 (26.2)

TAG

16 (13.1)

2

11 (9.0)

HDL-C

24 (19.6)

3

3 (2.5)

Glucose

14 (11.5)

Blood Pressure

0 (0)

Values are counts (percent), MetS, metabolic syndrome; TAG, triglycerides; HDL-C,
high-density lipoprotein cholesterol
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Figure 1: Average WG intake by source
3
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Figure 2: Average concentration of total AR and AR homologues
80

Plasma concentration (nmol/L)

70
60
50
40
30
20
10
0

Total AR

C17:0

C19:0

C21:0

Bars represent means ± standard errors

16

C23:0

C25:0

Figure 3: Log total WG intake vs log total plasma AR concentration
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Table 3: Correlation coefficients (rs) between plasma AR concentration and various
measures of WG intake
Total (n=122)

Males (n=36)

Females (n=86)

Total WG intake

0.24**

0.33*

0.18

Total fiber intake

0.28**

0.34*

0.24*

WG breads

0.27**

0.39*

0.21*

WG cereals

0.20*

0.25

0.14

* p < 0.05, ** p < 0.01
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Table 4: Correlation coefficients (rs) between WG and AR by gender
Total (n=122)

Males (n=36)

Females (n=86)

Total AR

0.24**

0.33*

0.18

C17:0

0.20*

0.35*

0.10

C19:0

0.24**

0.38*

0.18

C21:0

0.25**

0.39*

0.19

C23:0

0.22*

0.36*

0.11

C25:0

0.20*

0.30*

0.13

* p < 0.05, ** p < 0.01
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Figure 4: Correlation coefficients (rs) between plasma AR concentrations and WG
intake measures in males and females
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Table 5: A) Participant characteristics by plasma AR concentration quartile and B)
WG intake quartile agreement with plasma AR concentration quartile
A)

Q1 (n=31)

Q2 (n=30)

Q3 (n=30)

Q4 (n=31)

AR (nmol/L)

13.4 ± 0.84

27.7 ± 0.74

52.3 ± 2.19

151.7 ± 16.2

WG (Oz servings/day)

1.30ab ± 0.19

1.7ab ± 0.34

1.9b ± 0.39

TAG (mg/dL)

1.12a ±
0.35
77.9a ± 8.1

78.41ab ± 8.2

86.9ab ± 7.6

112.5b ± 11.1

TC (mg/dL)

144.2 ± 4.2

147.5 ± 5.4

142.8 ± 3.9

156.6 ± 6.6

BMI (mg/dL)

23.6 ± 0.72

22.7 ± 0.48

24.2 ± 0.85

23.3 ± 0.67

Fiber (g/day)

14.7a ± 1.4

14.9ab ± 0.9

17.9ab ± 1.6

20.2b ± 1.9

WG Intake (servings/d)

1.12 ± 0.35

1.30 ± 0.19

1.72 ± 0.34

1.91 ± 0.39

Same or adjacent Q (%)

67.7

73.3

78.1

58.6

Gross misclassification (%)

9.7

B)

13.8

Different a,b indicates significant difference by Tukey’s post hoc test, p < 0.05,
Cohen’s weighted kappa for agreement between AR and WG quartiles = 0.15
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Table 6: Food determinants of plasma AR concentration
Intake
Variable

Univariate
Analysis

Multivariate
Analysis

Intake
Variable

WG Bread

Univariate
Analysis

Multivariate
Analysis

WG Cereal

C17:0

0.12 (0.09)

0.11 (0.10)

C17:0

0.17 (0.09)

0.15 (0.09)

C19:0

0.25 (0.10)*

0.26 (0.09)*

C19:0

0.18 (0.09)

0.13 (0.09)

C21:0

0.25 (0.10)*

0.27 (0.09)*

C21:0

0.23 (0.09)*

0.18 (0.09)*

C23:0

0.19 (0.09)*

0.19 (0.09)*

C23:0

0.21 (0.09)*

0.18 (0.09)*

C25:0

0.17 (0.09)

0.17 (0.10)

C25:0

0.15 (0.09)

0.13 (0.09)

Total AR

0.23 (0.09)*

0.25 (0.09)*

Total AR

0.19 (0.09)*

0.15 (0.09)

RG Bread

RG Cereal

C17:0

0.04 (0.08)

0.08 (0.10)

C17:0

0.00 (0.09)

0.00 (0.09)

C19:0

0.06 (0.09)

0.14 (0.09)

C19:0

0.04 (0.08)

0.04 (0.08)

C21:0

0.11 (0.09)

0.19 (0.09)*

C21:0

0.07 (0.10)

0.07 (0.08)

C23:0

0.08 (0.09)

0.14 (0.09)

C23:0

0.02 (0.07)

0.03 (0.09)

C25:0

0.05 (0.08)

0.11 (0.09)

C25:0

0.03 (0.09)

0.04 (0.08)

Total AR

0.10 (0.09)

0.18 (0.09)*

Total AR

0.04 (0.09)

0.04 (0.09)

Multivariate
R2
C17:0

0.056

C19:0

0.099

C21:0

0.134

C23:0

0.091

C25:0

0.064

Total AR

0.113

Values are standardized beta coefficients (standard errors) for univariate and
multivariate models, multivariate models included whole-grain and refined-grain
bread and cereal as predictors
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APPENDIX A: LITERATURE REVIEW
Introduction
Although the inverse association between whole-grain intake and chronic
disease is well established (1-3), many challenges still exist in measuring whole-grain
intake, particularly in large studies (4, 5). Whole-grain intake is associated with lower
risk of cardiovascular disease (CVD), type 2 diabetes and obesity (3, 6, 7). Increased
consumption of whole-grains has also been associated with lower risk of metabolic
syndrome, which is a significant predictor of heart disease, diabetes and stroke (1, 8).
However, commonly used dietary data collection methods such as food frequency
questionnaires and 24 hour recalls are prone to estimation error and are usually time
intensive for both data collectors and respondents (9). This is further complicated by
the numerous definitions of “whole-grain” that are used by researchers when
formulating questionnaires and study criteria (4). The Food and Drug Administration
has attempted to implement a universal definition, but many organizations still
maintain their own (5). In light of the challenges associated with accurately collecting
and assessing dietary data, many researchers have turned to biomarkers as objective
indicators of nutrient intake. This is an active area of research and examples of
successfully implemented biomarkers include urinary nitrogen to assess protein intake
and doubly labeled water to assess total energy intake (10, 11).
Researchers have begun to explore the use of plasma alkylresorcinol (AR)
concentrations as a biomarker of whole-grain wheat and rye intake (12-14).
Alkylresorcinols are phenolic lipids that are obtained in the diet almost exclusively
from the bran of wheat and rye. Numerous controlled feeding trials have found that
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plasma AR levels reflect whole-grain wheat and rye consumption with r values
ranging from 0.25 to 0.97 (10). Additionally, in a review of the validity of over 20
novel biomarkers, Hedrick et al. (10) found that plasma AR level was only one of two
biomarkers to meet acceptable standards in three critical criteria: validity,
reproducibility and sensitivity. Due to these positive initial results researchers have
tried to correlate plasma AR concentrations with the same positive health outcomes
associated with whole-grain intake. So far, the fewer than 10 studies conducted with
this objective have found that higher plasma AR concentration is associated with
lower incidence of colorectal cancer, higher insulin sensitivity, slightly lower body fat
percent and lower BMI (15-19).
This literature review will explore the utility of ARs as a biomarker of wholegrain intake and will discuss the necessity of a whole-grain biomarker, the
characteristics of ARs, their use in research to date and limitations in their use.
Whole-Grain Intake and Chronic Disease Risk
Negative associations between whole-grain intake and CVD (20-24), type 2
diabetes (25-28), metabolic syndrome (1, 29, 30) and all-cause mortality (31, 32) have
been reported for decades. These results have been collected through primary research
and confirmed through meta-analyses, which represent hundreds of thousands of
subjects and efficiently convey cardiometabolic-protective effects.
Whole-Grain Intake and Cardiovascular Disease
In 2014 Wu et al. (33) published a meta-analysis examining the association
between dietary fiber intake and coronary heart disease (CHD) in cohort studies. The
systematic literature search was done on PubMed and EMBASE covering all articles
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published through May 2013. In total 532 relevant articles were identified, of which
18 met all inclusion criteria, including availability of relative risks or hazard ratios for
the primary outcome and a number of relevant confounders. The primary outcomes
were pooled relative risk for CHD incidence and mortality in the highest versus lowest
intake groups. This analysis was also performed for each dietary fiber subtype (cereal,
fruit and vegetable). The secondary outcome was to quantify a dose-response
relationship between fiber intake and CHD incidence and mortality in the 13 studies
for which this data was available.
The multivariate adjusted risk ratios showed a significant inverse association
between cereal fiber intake and CHD incidence (pooled RR = 0.92; 95% CI [0.850.99], P = 0.032) and between cereal fiber intake and CHD mortality (pooled RR =
0.81; [0.72-0.92], P = 0.001). The only other significant finding in the fiber subtype
analyses was an inverse association between fruit fiber and CHD incidence (pooled
RR = 0.92; [0.86-0.98], P = 0.01). Significant dose-response relationships were
observed for total fiber intake. Each 10 gram per day increase in total fiber was
associated with an 8% decrease in the risk of a coronary event (pooled RR = 0.92;
[0.87-0.97]) and a 24% decrease in risk of death (pooled RR = 0.76; [0.65-0.88]).
Dose-response analyses were not performed on fiber subtypes due to limited
availability of data.
In 2006 Mellen et al. (2) performed a meta-analysis on prospective cohort
studies that looked at associations between whole-grain intake and cardiac events.
Their systematic literature review was done on MEDLINE covering from 1966
through April 2006. Eight studies from seven cohorts met all inclusion criteria, which
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included having a prospective design, quantitative measures of whole-grain intake and
clinical confirmation of cardiovascular events. For analyses, participants were split
into whole-grain intake quintiles within study and odds ratios for cardiac events were
computed using models adjusted for demographic characteristics and cardiovascular
risk factors. The variance weighted odds ratios were then combined to determine an
overall effect.
The demographicadjusted model showed a
37% decrease in risk of
incident cardiovascular
disease between the highest
and lowest quintiles of
whole-grain intake (OR 0.63;
95% CI [0.58-0.68]). The

Figure 1 Odds ratios of incident CVD in high vs low whole-grain intake
quartiles from studies in meta-analysis by Mellen et al. 1Demographicadjusted model. 2Demographic and cardiovascular risk factor adjusted
model.

demographic and cardiovascular risk factor-adjusted model showed a 21% decrease in
risk (OR 0.79; [0.73-0.85]) (Figure). They also investigated a number of secondary
outcomes and found similar results when analyses were limited to men (OR 0.82;
[0.73-0.92]), women (OR 0.79; [0.68-0.91]), fatal endpoints (OR 0.78; [0.70-0.88])
and incident coronary heart disease (OR 0.76; [0.69-0.83]). They also analyzed risk of
cardiovascular event based on refined grain intake and found no significance (OR
1.07; [0.94-1.22]).
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Whole-Grain Intake and Metabolic Syndrome/Obesity
In 2006 Sahyoun et al. (1) published a cross-sectional study looking at the
association between whole-grain intake and metabolic syndrome prevalence and
mortality in older adults. Initial data collection took place between 1981-1984 on 747
community-living adults aged > 59 years. Participants kept 3-day food records which
were reviewed by a registered dietitian for completeness and accuracy. Biochemical
values were assessed from a fasting venous blood draw, and demographics and
anthropometric measures were collected by trained nurse practitioners. Metabolic
syndrome was defined as having at least three of the follow risk factors: triglycerides
≥150 mg/dL, HDL-C <40 mg/dL in men or <50mg/dL in women, blood pressure
≥130/85 mm Hg or on blood pressure lowering medications, fasting blood glucose
>100 mg/dL and BMI ≥31 in men or ≥27 in women (34). In 1995, the vital status of
the participants was assessed by examining the annual national index of death and
obtaining death certificates to confirm death index entries. Cause of death was attained
from death certificates. If vital status was unascertainable then the participant was
assumed to be alive.
Fasting blood glucose and BMI significantly decreased across whole-grain
intake quartiles (p = 0.01 and 0.03 respectively) in ANCOVA adjusting for
demographic and lifestyle factors. Odds ratios for having metabolic syndrome were
0.58-0.41 for whole-grain intake quartiles 2-4 compared to quartile 1 (p trend = 0.005)
in logistic regression adjusted for relevant risk factors. There was a significant inverse
trend between whole-grain intake and CVD-related mortality. Compared to wholegrain intake quartile 1, quartile 4 had a significantly lower risk of CVD-related
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mortality (relative risk (RR); 95% CI = 0.48; 0.25-0.96). No associations between
whole-grain intake and all-cause mortality were observed.
A number of studies have also looked at associations between whole-grain
intake and weight status. In 2003 Liu et al. (7) performed an analysis on data from the
Nurses’ Health Study focusing on associations between whole-grain and fiber intake
and weight changes and BMI. The analyzed sample consisted of 74,091 female
registered nurses between the ages of 30-55 years at time of recruitment. Dietary
intake was assessed by a 60-item semiquantitative FFQ that was administered in 1984,
1986, 1990 and 1994. Body weight was self-reported at the same time points and
weight change was assessed as the differences between two year intervals and overall
difference from 1984 to 1994. Analyses were performed across quintiles of dietary
intake variables and were adjusted for age, exercise, smoking, hormone replacement
therapy, alcohol and caffeine intake.
At baseline, women in the highest quintile of whole-grain intake weighed
significantly less and had significantly lower BMIs compared to women in the lowest
intake quintile (p trend < 0.0001). Over the 10 years of observation, women in the
highest quintile of whole-grain intake gained significantly less weight than women in
the lowest quintile (1.07 vs 1.58 kg, p trend < 0.0001). Similar results were observed
for dietary fiber intake; over the 10 years of follow up the women who increased their
dietary fiber intake the most, gained an average of 1.52 kg less than those who
increased their fiber intake the least (p trend < 0.0001). The risk for developing
obesity (BMI ≥ 30) was also significantly lower in the highest whole-grain intake
quintile compared to the lowest (odds ratio; 95% CI = 0.81; 0.73-0.91).
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Whole-Grain Intake and Type 2 Diabetes
In 2014 Yao et al. (35) conducted high versus low and dose-response metaanalyses of prospective cohort studies that looked at dietary fiber intake and incidence
of type 2 diabetes. Systematic literature searches were conducted on EMBASE
covering 1974 through April 2013 and PubMed covering 1966 through April 2013.
Seventeen studies met the inclusion criteria, which included having a prospective
design, using dietary fiber or a dietary fiber subtype as the main exposure, using type 2
diabetes as the primary outcome and including adjusted risk ratios with 95%
confidence intervals. To assess risk with high versus low whole-grain intake a
combined measure was calculated using the inverse variance-weighted mean of the
natural log-transformed covariate-adjusted risk ratio of the highest compared to lowest
intake group in each study. Both linear and non-linear methods were used to assess
dose response.
The final
analysis included 17
prospective studies
including 488,293
participants
published between
1997-2013. The
Figure 2 Dose-response between total fiber intake and risk of type 2 diabetes from
meta-analysis by Yao et al. Solid line represents the linear mode, dashed line is
nonlinear model with 95% CI.

high versus low

analysis showed that the low cereal fiber intake group had a significantly lower risk of
developing type 2 diabetes (RR; 95% CI = 0.77; 0.69-0.85). The risk reduction for
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cereal fiber was greater than for fruit fiber (RR = 0.94) and vegetable fiber (RR =
0.95). Linear dose response modeling showed a 6% decrease in risk of type 2 diabetes
for every 2g/day increase in cereal fiber (RR; 95% CI = 0.94; 0.93-0.96).
Randomized Controlled Feeding Trials
A limited
number of
randomized
controlled trials have
shown potential
mechanisms
underlying the
inverse association
between whole-grain

Figure 3 Fasting insulin concentrations from overweight or obese adults (N=11)
during refined grain or whole-grain intervention. Values are means ± SE. Table
from Pereira et al.

intake and cardiometabolic risk seen in epidemiologic studies (26, 36-38). In 2002
Pereira et al. (26) tested the effects of a six week whole-grain vs. refined grain diet
intervention on insulin sensitivity measured by a euglycemic hyperinsulinemic clamp
test and fasting insulin. Participants (N=11) were hyperinsulinemic, nondiabetic,
overweight or obese and 25-56 years old. The researchers provided all foods for the
entire 6 weeks and participants were asked to consume no other food. All participants
received both diets in a random order with a 6-9 week washout period between. Both
diets used identical food items with the only difference being the use of whole or
refined grain. The whole-grain diet was higher in fiber (28.0 vs 17.8 g/day) and
slightly higher in some minerals, but the diets had otherwise identical nutrient
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contents. During the whole-grain diet, fasting insulin levels were significantly lower
and insulin sensitivity was significantly higher compared to baseline and the refinedgrain diet at weeks 2, 4 and 6. Additionally, the area under a 2-hour insulin
concentration curve after a liquid non-grain test meal tended to be lower after six
weeks of the whole-grain diet compared to the refined-grain diet. Fasting blood
glucose also tended to be lower after the whole-grain diet but the difference was not
significant.
In addition to euinsulinemic effects, others have hypothesized that the benefits
of whole-grains are related to bioactive compounds such as lignins and phenols that
have shown antioxidant effects in animal and cell models (39, 40). These results have
been difficult to translate into humans and only a limited number of studies have been
attempted with mixed results (36-38). Part of the difficulty in conducting these studies
are the numerous operational definitions of “antioxidant status”. It is also difficult,
logistically and financially, to model the long-term moderate doses seen in
epidemiologic studies in an experimental design.
These data, comprised of observations on over 600,000 individuals, provide
strong evidence that increasing intake of whole-grains may decrease risk of a number
of chronic diseases. However, whole-grain intake was quantified in all of these studies
using self-reported dietary intake data which presents some unique methodological
challenges.
Challenges in Quantifying Dietary Intake
Quantifying whole-grain intake in free-living populations is a challenging
process that is complicated by a number of factors. First, the most widely used
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methods of collecting self-reported dietary data are subject to systemic biases that can
attenuate or altogether hide nutrient-disease relationships (11, 41, 42). The second
issue is that there is not a universal definition of “whole-grain” used in research or
industry (43). This lack of a universal standard leads to inconsistency across research
and reporting, particularly regarding enrichment with components of whole-grains.
Industrial labeling practices can also cause consumer confusion leading to inaccurate
reporting of whole-grain intake (5). Many consumers do not have a firm grasp on what
constitutes a whole-grain product and when that is combined with nebulous labeling
and multi-grain formulations the chance for errant reporting increases.
Challenges in Quantifying Dietary Intake
Food frequency questionnaires (FFQ) and 24-hour dietary recalls (24HR) are
two of the most widely used methods of collecting dietary intake data, and both are
subject to substantial systematic and random error (41, 42, 44). Systematic error is
inherent to the specific tool being used, has a non-zero mean and is very difficult to
identify without using another validation tool (45). This type of error will affect all
observations, or large subsets of observations, in a similar way, creating distinct
patterns of error. An example of this type of error in dietary reporting is the systemic
bias of under-reporting. In 2003 Livingstone et al. (11) conducted a meta-analysis of
43 studies that compared self-reported energy intake to observed energy intake using
doubly labelled water (DLW), an objective biomarker of energy intake (46). They
found that the average percent of energy reported across all studies was 83±14% of
that observed with DLW, indicating average under-reporting of 10-20%. They also
noted that women and individuals with higher BMI under-reported to a greater extent.
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Additionally, every method of dietary self-reporting (weighed records, estimated
records, diet history, 24HR and FFQ) showed similar under-reporting, ranging from
13-16%.
Random error can affect any tool being used and has a mean zero, affecting all
observations in a non-uniform manner (47, 48). In dietary self-reporting random error
usually comes from unpredictable variation in intake across days or seasons. For
example, a participant may perform a 24HR on an unusual, non-representative day
which will introduce some error that cannot be accounted for. Although it is difficult
to mode random error out of data, in a study with a large sample and repeated
measures it does not have as strong of an influence on the results as systematic error
(49).
Food frequency questionnaires (FFQ) are widely used in epidemiologic studies
because of their low researcher burden, however, they are subject to both systematic
and random error (41, 42, 44). The FFQ is a tool that measures usual dietary intake
over a defined time period and can be used on a large scale due to its relatively low
burden on researchers. This has made it the primary tool of choice for most large
epidemiologic studies examining diet-disease relationships. However, the FFQ is
subject to bias because it asks participants to recall intakes over long periods of time
leading to error-prone estimation. This estimation leads to a “flattened slope”
phenomenon wherein subjects with high intake of an item tend to underestimate their
intake and subjects with low intake tend to overestimate, reducing the true range of
intakes (50). This phenomenon effectively reduces the power to detect diet-disease
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relationships in a sample and, when coupled with classical random error, has the
potential to attenuate any underlying relationships (9).
The other major method, 24HR, is considered a more accurate measure of
short-term intake and is often used to “calibrate” FFQs to remove some of the
systematic error (49). Although this method is considered more accurate, it is often
interviewer administered which puts greater burden on researchers and is still subject
to considerable systemic error (11). The sources of systematic error are different with
the 24HR method, and are suspected to include consistent underestimation of portion
sizes and potential misreporting to meet perceived expectations of interviewers (51).
These data show that both FFQs and 24HRs are subject to systematic and
random error and generally tend to show underreporting of total energy and individual
food items and nutrients. These biases have the potential to attenuate true diet-disease
relationships that may exist in epidemiologic studies and are part of the reason for
inconsistent, conflicting results.
Challenges in Quantifying Whole-Grain Intake
The quantification of whole-grain intake by self-report is also strongly affected
by the lack of a universal definition of whole-grain and by consumer inability to
interpret nutrition labels and identify whole-grain products. Within the United States, a
number of governing bodies maintain whole-grain definitions. However, the most
widely used definition is the Food and Drug Administration’s which was adopted from
the American Association of Cereal Chemists and states that whole-grains consist of
“intact, ground, cracked or flaked fruit of the grains whose principal components – the
starchy endosperm, germ and bran – are present in the same relative proportions as
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they exist in the intact grain.” (4). This definition was adopted in 2006 and
subsequently the FDA approved a number of label statement health claims regarding
the relation of whole-grain intake and cancer and CVD. However, most of the research
that the FDA based the approval of these claims on was done using broader definitions
of whole-grain. In 2009, De Moura et al. (4) revisited the evidence the FDA used to
approve these claims and found that only 2 out of 29 studies adhered to the 2006 FDA
definition. This led the authors to conclude that there is insufficient evidence to
substantiate most whole-grain related health claims when the FDA definition is
applied to research. A number of leading cereal grain researchers recently collaborated
on a paper addressing the issue of whole-grain definitions in research and came up
with five recommendations for rigorous quantification of whole-grain intake (43).
These include quantifying whole-grain content in food on a dry weight basis,
identifying the whole-grain definition used, reporting different types of grains with
enriched germ and bran reported separately and noting the milling and processing of
the grains. These standard would reduce or eliminate most of the inconsistency in
whole-grain research, however, exceedingly few studies meet all of these reporting
recommendations.
These reporting recommendations are also not met on most commercially
available food products, which leads to consumer confusion and inability to identify
whole-grain items (43). Many different terms are used to describe grain products on
labels including whole-grain, whole-meal, multi-grain, cereal, 100% whole-grain and
partial whole-grain. The rise of alternative grains and pseudograins like couscous,
buckwheat and quinoa have also led to consumer confusion due to difficulties in
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identifying items, first as a grain and second as a whole-grain (5). All of these factors
combine to make it very difficult to accurately quantify whole-grain intake in freeliving populations in order to elucidate diet-disease relationships. This has led
researchers to seek an objective biomarker of whole-grain intake to attenuate or
circumvent these challenges completely.
Alkylresorcinols
Biomarker Characteristics
Biomarkers can help circumvent many of the issues with self-reported diet
intake assessment and are an important research area in nutritional science (52).
Dietary intake biomarkers are objectively measureable molecules that can be used to
quantify recent intake of a specific food item or nutrient and are most commonly
measured in blood and urine (11, 53). Intake biomarkers help to assess actual intake
versus self-reported intake, validate compliance during controlled feeding trials,
evaluate intake of specific nutrients when nutrition research databases are inadequate
and reduce error-induced bias when evaluating diet-disease relationships (10). In 2007
during a meeting on establishing dietary reference intakes, the Institute of Medicine
noted that the lack of dietary intake biomarkers is an important research gap that must
be addressed in order to better evaluate diet-disease relationships and improve overall
nutritional assessment (52).
Dietary biomarkers can be grouped into two classes; concentration and
recovery (54). Concentration biomarkers are based on a concentration measurement at
a single timepoint in a body fluid or tissue sample. These biomarkers provide a rough
estimate of intake, but are subject to higher inter-individual variability and cannot be
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translated into an absolute quantitative measure of intake (55). Factors such as
endogenous production, enzymatic metabolism or absorption may affect the amount of
these biomarkers that are found in samples between individuals (56). Another class,
recovery biomarkers, exhibit a defined and well-characterized balance between intake
and excretion for all individuals in a population (57). Because recovery is always a
fixed proportion of intake for all individuals, intakes can be accurately computed from
measures of these biomarkers(58). Relatively few recovery biomarkers have been
discovered and widely used. The three most commonly used are urinary nitrogen to
measure protein intake, urinary potassium to measure potassium intake and doubly
labelled water to measure total energy intake (10).
Biomarkers are further classified into time classes by the period of time over
which they reflect intake. Short term biomarkers reflect intake over hours to days,
medium term reflect weeks to months and long term reflect months to years (10). The
time class is primarily determined by the type of sample required to detect biomarker.
Short to medium term biomarkers are usually detected free in plasma or urine.
Medium to long term biomarkers are usually detected in red blood cells, hair or
adipose tissue biopsies. The rate of metabolism and extent of storage of biomarkers
are the primary determinants of their time class (10).
Alkylresorcinols
Recently a group of phenolic lipids called alkylresorcinols (ARs) has been
proposed as a short to medium term concentration biomarker of whole-grain intake
(59-61). These molecules are dihydroxylated phenols with an alkyl side chain of
variable length. The length of the alkyl chain determines the AR homologue identity.
42

Dietary ARs are obtained almost exclusively in the bran of whole-grain wheat and rye.
Refined wheat and rye have very low AR contents due to the removal of the bran
during processing, making AR a potentially good biomarker for intake of these wholegrains. The ratio of AR homologues varies between grain species with rye having a
C:17/C:21 ratio near 1 and wheat having a C:17/C:21 ratio near 0.1, allowing for
further specificity in quantifying intake (62).
Absorption
Alkylresorcinols are readily absorbed and systemically distributed in the body
with consistent pharmacokinetics. Confirmation of AR absorption was provided in
studies by Ross at al. (63, 64) which used an ileostomy model in pigs and humans. In
the pig study, four experimental diets comprised of bread made from differing milled
rye fractions were fed to ileal cannulated pigs three times per day for two weeks.
Ileostomy effluent was collected on days 12 and 14 and analyzed for AR recovery. No
AR was detected in effluent from pigs consuming bread made with endosperm only.
Recovery values from bran-containing treatment groups ranged from 20-40%
indicating that 60-80% of ingested AR was absorbed in the proximal small intestine. A
dose effect was observed, with the highest AR treatments showing lower absorption
than low AR treatments. No major differences in homologue absorption were
observed.
These results were corroborated in crossover study in 10 human ileostomy
patients ages 34-51 years (63). This study consisted of a high and low AR diet with
two meal frequencies within each diet. Each participant completed two weeks of the
high and low AR diets with one week of each meal frequency within the diets. There
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was a two week AR-free diet run-in and a one week washout between diet treatments.
When consuming about 215 mg/day AR via rye bread on the high AR diet, AR
recovery in ileostomy effluent was about 40%, indicating about 60% absorption in the
proximal small intestine. There was no effect of meal frequency on absorption, but
longer chain homologues (C:23 and C:25) showed significantly lower absorption than
shorter chain homologues (C:17-C:21).
Despite strong evidence that AR are absorbed in the small intestine, the
molecular mechanism for absorption is not known. It has been hypothesized that, due
to their structural similarities, AR may be absorbed in a similar manner to tocols
which are taken up by scavenger receptor class B and incorporated into chylomicrons
for lymphatic transport or directly transferred to HDL particles (65). Although the
mode of absorption in not definitively known, ARs show consistent plasma kinetics
after ingestion.
Metabolism and Excretion
The catabolic mechanisms for AR are not fully understood, but limited
experimental evidence and inferences from structurally similar molecules have given
some clues. In vitro studies have provided strong evidence for the first step in the AR
metabolic pathway (66). In a series of experiments published in 2013, Marklund et al.
(66) used three in vitro models to investigate the initial steps of AR metabolism. The
three model systems were insect microsomes expressing human CYP4F2, human liver
subcellular fraction S9 and HepG2 human hepatocytes. Each system was incubated
with the AR homologue C19:0 at multiple combinations over multiple time courses.
Alkylresorcinol metabolites were analyzed in media samples using gas
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chromatography-mass spectrometry (GC-MS) and high performance liquid
chromatography with electrochemical detection. Due to structural similarities, it was
hypothesized that ARs are metabolized similar to tocopherols, which are
biotransformed to allow for β-oxidation, resulting in the formation of two metabolites
that are excreted in the urine.
It was hypothesized that the first step in AR catabolism is CYP-mediated ωoxidation. To test this, CYP4F2-expressing microsomes were screened for
hydroxylated AR after an incubation with C19:0. Hydroxylated AR was found in
incubated samples and was absent in control samples, supporting ω-oxidation as the
first step of AR catabolism. This result was confirmed in human liver S9, supporting
ω-oxidation of ARs by human hepatic microsomal enzymes. Alkyl chains must
ultimately be carboxylated to allow for β-oxidation, and carboxylated AR was also
observed at lower concentrations in S9 fractions after AR incubation. Finally,
researchers checked for 3,5-dihydroxybenzoic acid (DHBA) and 3-(3,5dihydroxyphenyl)-propanoic acid (DHPPA), which are the end products of βoxidation of AR, in HepG2 cells incubated with C19:0. They found DHPPA but were
not able to detect DHBA, possibly because of its higher limit of detection. These
results support hepatic ω- and β-oxidation as primary AR catabolic pathways resulting
in DHPPA and DHBA formation which have been proposed as the primary excretory
metabolites (67-69).
Pharmacokinetics
Despite incomplete information on their biotransformation, AR
pharmacokinetics have been characterized (66, 70-74). In 2006 Linko et al. (70)
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performed two experiments investigating the appearance and clearance of ARs in
plasma using a pig model under controlled feeding conditions. In the first experiment,
four pigs were fed a refined-grain wheat enriched diet or a whole-grain rye enriched
diet for one week in a crossover design. The diets were approximately equivalent in
most macro- and micronutrients except ARs (1158 vs 0 µg/g in rye vs wheat).
Multiple blood samples were taken on days 5 and 7 around feeding at -30, 0, 30 and
60 minutes then every 60 minutes up 480 minutes post-feeding. In the second
experiment, four pigs were fed an AR-free diet for 5 days, then on the morning of day
6 were fed the whole-grain rye enriched diet. Blood samples were taken around
feeding at -30, 0, 30 and 60 minutes, then every 60 minutes up to 960 minutes postfeeding. This experiment was performed twice in the same animals.
In the first
experiment pigs fed the
refined wheat enriched
diet showed basal AR
concentrations of 35±4
Figure 4 Appearance of AR in plasma from the portal vein and mesenteric
arteries of pigs (N=4) after a single rye meal intake. Values are means ± SD.
From Linko et al.

nmol/L before feeding
and a peak concentration

of 74±7.5 nmol/L at 180 minutes post feeding despite having no detectable ARs in the
feed. Pigs fed the rye enriched diet consumed approximately 1244 µmol of AR per
feeding. They showed a basal concentration of 260±77 nmol/L before feeding and a
peak concentration of 662±92 nmol/L at 240 minutes post feeding. At 480 minutes,
concentrations were still significantly elevated compared to baseline (370±52 nmol/L).
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In the second study, pigs consumed an approximately 1471 µmol of ARs in a
single feeding. Baseline AR concentrations were 30±3.7 nmol/L before feeding.
Levels began to rise at 60 minutes post feeding and peaked at 180-240 minutes post
feeding (666±35 nmol/L). At 960 minutes post-feeding, concentrations were still
significantly elevated compared to baseline (136±34 nmol/L) (figure 4). Blood was
drawn from mesenteric arteries and portal veins with no observed differences in AR
concentrations between the two sources. This suggests that ARs are not directly
absorbed into capillaries at the basolateral aspect of intestinal absorptive enterocytes
and must enter the blood via lymphatic circulation. The relatively long times needed
reach peak plasma concentrations (3-4 hours) also support lymphatic uptake.
In 2006 Landberg et al. (71) confirmed these finding in humans. Participants
(N=6) were 50% female with an average age of 26±1.1 years and an average weight of
74±3.9 kg. One week before the study participants were instructed to avoid any foods
containing whole-grain wheat or rye or bran from wheat or rye. On the test day
participants were given a 120 g portion of rye bran containing approximately 495 µg
of ARs. Participants consumed at least 200 mL of 3% fat yogurt with the rye bran
because fat is hypothesized to aid in AR absorption (75). Blood samples were taken at
baseline and at 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 and 24 hours post intake. Participants
were fed a standardized, AR-free lunch four hours after intake, then all dietary
restrictions were lifted.
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Baseline samples showed less
than 2 nmol/L ARs after the one week
run-in. After intake, two major
concentration peaks were identified.
The first peak occurred at 2.4-3.4
hours post intake with a concentration
of 1253±123 nmol/L. The second peak
occurred at 6.5 hours post intake with
a concentration of 3365±309nmol/L

Figure 5 Total plasma AR concentrations from human
plasma (N=6) after a single rye bran flake meal. From
Landberg et al, 2006.

(figure). The observed half-life was 4.8 hours. Differences were noted in
bioavailability with longer chain lengths showing higher bioavailability. This trend fit
an exponential curve and was significant (R2=0.97, P<0.05). The relatively short
plasma half-lives observed in these experiments show that ARs may function best as a
short to medium term whole-grain intake biomarker.
Once in circulation ARs have been shown to travel in lipoproteins. In 2007
Linko-Parvinen et al. (14) conducted a study looking at alkylresorcinol distribution in
components of blood after controlled feeding of wheat and rye breads. Fifteen healthy,
normal weight (BMI 24.4±0.99 kg/m2) Nordic men and women (age 21-36 years)
were included in the randomized crossover design. Participants consumed only refined
breads for a one week baseline period then were randomized to either 100 g/day of
whole-grain wheat or rye crisp bread for one week. The first treatment was followed
by a one week washout then the second treatment. Blood samples were taken before
the refined grain baseline, after each one week period and one week after completion
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of the trial. Alkylresorcinol concentrations were determined plasma, erythrocytes and
lipoproteins via gas chromatography–mass spectrometry.
Results showed that whole-grain wheat and rye treatments both increased
overall plasma AR concentrations compared to habitual diet and baseline/washout
periods. Over 70% of ARs measured in plasma were accounted for in the lipoprotein
fraction. When accounting for loss of sample in lipoprotein isolation the authors
speculated that over 80% of ARs could be contained in the lipoprotein fraction.
Lipoprotein-deficient plasma showed no detectable ARs, strengthening the hypothesis
that ARs are transported almost exclusively in lipoproteins. Within the lipoprotein
fraction in fasting blood samples, very low-density lipoprotein (VLDL) particles
contained the highest proportion of ARs (46±2.1%) followed by HDL particles
(33±1.5%) and LDL particles (20±1.3%). The authors also speculated that ARs are
likely absorbed, incorporated into chylomicrons, transported into circulation via the
lymphatic system and incorporated into VLDL in the liver, similar to tocopherols.
These data illustrate the lipophilic nature of ARs and suggest that changes in blood
lipid profile may affect AR metabolism.
In addition to incorporation into lipid fractions, acute and habitual
consumption of ARs has been shown to result in their accumulation in adipose in rats,
pigs and humans. In 2004 Ross et al. (76) conducted an experiment to examine the
effects of ARs on growth and tocopherol metabolism in rats. Rats (N=32) were fed
ARs isolated from rye bran at 0, 1, 2 or 4 g/kg diet for four weeks. After four weeks,
rats were fasted for 12 hours, euthanized, and blood, liver, lung and perirenal adipose
samples were collected. Samples were analyzed for lipid, AR and tocopherol content.
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Analyses showed that ARs accumulated in the perirenal fat pads of the rats in
concentrations as high as 4 µg/g fresh tissue. Diets higher in ARs also increased
serum, lung and liver tocopherol concentrations by inhibiting tocopherol-degrading
enzymes. This effect has not been well-characterized, but fits with other in vitro
findings such as suppression of lipolysis via inhibition of hormone sensitive lipase in
3T3-L1 adipocytes (77). Increased ARs also strongly decreased liver cholesterol
concentrations, but did not affect serum cholesterol levels. These data demonstrate that
ARs are sequestered in lipid depots at relatively high concentrations and may be able
to elicit systemic effects even after serum levels return to baseline. The liver-specific
reductions in cholesterol and systemic increases in tocopherols may also be part of the
mechanism underlying the cardioprotective effect of whole-grain wheat and rye.
Jansson et al. (78) also showed AR accumulation in adipose tissue of freeliving humans. In this study women (N=20) from the Swedish Mammography Cohort
had adipose tissue samples taken from an outer upper buttock quadrant, blood samples
taken and whole-grain intake quantified using a 123-item FFQ that reflected intake
over the prior six months. Alkylresorcinol content was quantified in the adipose and
blood samples using GC-MS.
Alkylresorcinol quantification in human adipose samples showed an average of
0.54±0.35 µg/g dry tissue with a range of below the limit of detection to 1.50 µg/g.
The authors speculated that the large variation could be due to a number of factors
including intake, bioavailability and adipose depot size. Alkylresorcinol content in
human adipose samples showed a significant positive correlation with total daily
whole-grain bread intake as quantified by FFQ (r = 0.48). These results confirm that
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ARs are stored in adipose tissue depots in humans, and suggest that AR concentrations
in adipose tissue may reflect longer term intake of whole-grains.
Once AR are absorbed they are rapidly metabolized and cleared from
circulation with a half-life of 5-7 hours (71). The full catabolic mechanism is not
known, but it is speculated to be similar to that of tocopherols which includes
conversion of the carbon chain to an acyl-CoA ester and subsequent β-oxidation (64,
79). This supposition has been bolstered by the discovery of AR metabolites (DHBA
and DHPPA) that are analogous to tocopherol catabolic end products (80). These
metabolites have been identified in plasma and urine and are the major form of AR
excreted in the urine (81).

Figure 6 After ingestion ARs are absorbed in the intestine and packaged into chylomicrons for
lymphatic circulation (A). Once in the blood ARs circulate in VLDL particles and are distributed to
other compartments like adipose tissue (B, C). ARs are metabolized in the liver to two major
metabolites which are excreted in the urine (E, D). ARs can also be excreted via biliary secretion (E,F).
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Collectively, these data show that dietary ARs are absorbed and metabolized in
the body and that they show adequate specificity to act as a biomarker for wholewheat and rye intake. In addition to specificity, good biomarkers must show dosedependency and reproducibility. These characteristics have been demonstrated in a
number of human trials.
Validation of Alkylresorcinols as a Biomarker
Controlled Feeding Trials
In 2009 Landberg et al. (59) conducted a controlled feeding trial to assess the
dose response of plasma ARs to increasing intakes of whole-grain rye. Fifteen
participants (N=9 women) with an average age of 30.6±10.3 years and an average
BMI of 23±3.3 kg/m2 were recruited from the Uppsala region of Sweden. The study
used a randomized, non-blinded, 3-way crossover design in which each participant
consumed three levels of rye bran for one week each with a one week washout period
between treatments. Fasting blood samples were taken before and after the one week
run in period and after each treatment and washout period. Participants were instructed
to maintain their habitual diet with the exception to avoid all whole-grain or bran of
wheat and rye during the week before and throughout the study. The treatments were
7.5, 15 or 30 g doses of rye bran flakes, containing 11, 22 and 44 mg ARs
respectively, which were taken three times per day.
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Blood samples prior to the run
in period showed an average plasma
AR concentration of 117±69 nmol/L
which dropped to 68±33 after the one
week run in period. Plasma
concentrations increased significantly
between each increasing treatment
(148±60, 210±81, 455±189, P>0.05)
as assessed by mixed linear model
using period and dose as fixed factors

Figure 7 Total plasma AR concentration by quartile of daily
AR intake estimated from weighed food records. N = 112.

and participants as a random factor. Within subject variability in AR concentration
was moderate at approximately 30%, as assessed using washout period values.
However, there was considerable between-subjects variability which was greatest at
the highest AR doses. Although a clear dose-response relationship was shown,
variability in the data complicated predictive modeling. The variability between
subjects forced the researchers to group participants into AR intake quartiles rather
than using AR as a continuous variable in the regression model, which made it
impossible to explicitly define a linear AR dose-plasma concentration relationship.
Additionally, predicted plasma AR concentrations derived from regression models
showed high variability despite attempting to keep intake at a steady state through the
study design. These complications led the researchers to conclude that plasma AR
concentration may be a good concentration biomarker, but is not a potential recovery
biomarker for whole-grain intake.
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In 2009 Landberg et al. (82) also investigated the reproducibility of plasma
ARs during a randomized non-blinded crossover whole-grain rye intervention in male
prostate cancer patients. Participants (N=17) were male and had clinically diagnosed
prostate cancer. Average age was 73.5±4.6 years and average BMI was 27.5±4.6
kg/m2. Participants received a whole-grain rye and a refined wheat diet separated by a
two week washout period. There was no run in period. Each intervention lasted six
weeks and participants were given 300g (3 pieces) of bread, 100 g (10 pieces) of crisp
bread, 50 g of breakfast cereal, 33 g porridge and 58 g of table spread each day.
Participants were instructed to consume the intervention products during breakfast,
lunch, dinner and two or three snacks each day. Participants were also instructed to
eliminate all other cereal products from their diets during the intervention periods.
Total AR content was approximately 6,800 µg/day for the whole-grain rye diet and 70
µg/day for the refined wheat diet. Fasting blood samples were taken before and after
the second, fourth and sixth weeks of each treatment period to measure plasma AR
concentration.
Actual daily AR intakes were 552±65 and 8.2±2.0 during rye and wheat
treatments respectively as assessed by multiple 4 day food logs. Average plasma AR
concentrations were 991±794 and 75±92 nmol/L during rye and wheat treatments
respectively. The intraclass correlation coefficient (ICC) was 0.90 (95% CI; [0.82,
0.98]) during the first intervention period and 0.99 (95% CI; [0.78,0.98]) during the
second intervention period. Although the ICCs were high, variability in the data still
made modeling exact intake difficult, even under controlled conditions. Confidence
interval modeling showed that during the first intervention period nearly 20 plasma

54

samples would be required to ascertain true mean plasma AR concentrations with a
5% precision (D) level and 95% confidence.
In 2012 Ross et al. (12) conducted an extended feeding trial comprised of 252
overweight or obese participants over a 16 week treatment period. Participants were
recruited at two centers in Newcastle and Cambridge, England. Participants were
overweight but otherwise healthy with low habitual whole-grain intake (< 30 g/day).
Participants were randomized into one of three treatment groups. The control group
was instructed to maintain their habitual diet and was not told that the study was
investigating whole-grains. The first treatment group was instructed to consume three
20 g servings of whole-grain foods per day along with their normal diet. The second
treatment group was instructed to consume three 20 g servings of whole-grain foods
during weeks 1-8 and to increase their intake to six 20 g servings during weeks 9-16.
All whole-grain foods were provided to the participants. Fasting blood samples were
taken at baseline and during weeks 8 and 16. Self-reported whole-grain intake was
also assessed at baseline and during weeks 8 and 16 via a 149 item FFQ.
Total whole-grain intake was significantly correlated with plasma AR levels in
all participants at week 16 (r = 0.35). Approximately 65% of the whole-grains
consumed throughout the study were from wheat, therefore the correlation between
whole-grain wheat intake and plasma AR levels was stronger than for overall wholegrain intake at week 16 (r = 0.43). Correlations were strongest in the overall study
population when whole-grain intakes were highest at week 16. Linear modeling
identified five significant predictors of AR concentration; whole-grain intake, gender,
non-esterified free fatty acids, triglycerides and study center location. Although
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triglycerides were a significant predictor in the overall model, they were only
correlated with plasma AR levels in males. This led to speculation that differences
between males and females in the overall model may be due to gender-specific
differences in lipid metabolism and distribution. As with other studies, interindividual
variability and confounding variables made it impossible to define a quantitative
model to predict whole-grain intake based on plasma AR levels. However, quartiles of
plasma AR levels were able to predict whole-grain intake quartile; 70-79% of
participants were classified in the same or adjacent quartiles and only 9-12% were
grossly misclassified into a non-adjacent quartile.
Although this was an intervention study it contained a number of naturalistic
elements that made it more applicable to free-living and epidemiologic studies. First,
compliance was measured through self-report using an FFQ rather than through
collection of unused food products. Second, other whole-grain products were not
excluded from participants’ diets and the control group was not restricted from
consuming whole-grains. Third, the study specifically targeted overweight and obese
individuals which is a group known to consistently misreport their intake to a greater
extent than other groups (11, 41, 83, 84). Despite the inclusion of these naturalistic
and confounding elements significant associations were still observed, strengthening
the case for plasma ARs as a whole-grain concentration biomarker.
Studies in Free-Living Populations
The ultimate goal of identifying dietary intake biomarkers is to better assess
habitual dietary intake in free-living populations, therefore, findings under controlled
feeding conditions must be replicable in non-experimental designs. Numerous studies
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have investigated the validity of ARs as a whole-grain intake biomarker in free-living
populations.
In 2008 Aubertin-Leheudre et al. (85) investigated the relationship between
cereal fiber intake and plasma AR levels in a group of Finnish women. Participants
(N=56) were an average age of 46±13 years, with an average BMI of 22.5±2.7 kg/m2
and 43% were post-menopausal. Participants filled out 5-day food records including at
least one weekend day on two occasions approximately 6 months apart. Fasting blood
samples were taken on the third day of the 5-day food record.
Results showed a
significant correlation between
total plasma AR and cereal fiber
intake (r = 0.379) (figure) as well
as between each individual AR
homologue (C:17-C:25) and
cereal fiber intake. Interestingly,
vegetarians (N=20) had a higher

Figure 8 Pearson’s correlation between cereal fiber intake and total
plasma AR. Cereal fiber intake assessed by 3d diet record. From
Aubertin-Leheudre et al. 2008.

correlation between total plasma AR and cereal fiber intake than omnivores (r = 0.548
vs 0.372) and also had higher cereal fiber intake (11.0±3.6 vs 9.5±2.6 g/day). These
results suggest that plasma AR may work better as a biomarker in individuals who
consume more whole-grains. This is consistent with findings from Ross et al. (12) and
invalidates plasma ARs as a recovery biomarker because it is not equally robust across
all populations. Regression analysis showed that plasma AR levels were not highly
influenced by age or BMI and they also did not significantly correlate with other types
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of fiber such as berry, legume and vegetable fiber. This shows that plasma ARs are
robust to confounding by age and BMI, and show adequate specificity in reflecting
only whole-grain intake. Although this study did show significant moderate
correlations between total plasma AR and individual homologues and cereal fiber
intake, the study design did not exactly reflect most dietary data collection methods
used in epidemiologic studies. Plasma AR levels were measured during the time that
diet was being monitored using food recalls, hence the measure was not reflecting
habitual diet in the same way that an FFQ usually does.
In 2011 Andersson et al. (60) conducted a similar study investigating the
effectiveness and reproducibility of plasma AR levels in a free-living population.
Participants (N=72) were recruited in and around Uppsala, Sweden and had an
average age of 42±17 years, an average BMI of 24.3±3.9 kg/m2 and were 76% female.
Participants completed two 3-day weighted food records 2-3 months apart after
receiving oral and written instructions on keeping food records and being provided
with a portable scale for measuring their intakes. At the end of each food record
period, the majority of participants (N=51) provided one fasting blood sample. A
subset of the participants (N=18) provided fasting blood samples on each day of the
first food record period and non-fasting blood samples on each day of the second food
record period.
Neither whole-grain intake or total fiber intake were significantly correlated to
total plasma AR levels at either time point (r = 0.24, 0.16 respectively). Total cereal
fiber intake and combined intake of whole-grain wheat and rye were significantly
correlated to total plasma AR levels (r = 0.32, 0.54 respectively). Fasting total plasma
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AR measures were significantly correlated over 2-3 months (rs = 0.38). Over 2-3 days
fasting plasma AR levels also showed high reproducibility (ICC = 0.60, 95% CI [0.36
– 0.80]) but non-fasting levels showed low reproducibility (ICC = 0.18, 95% CI [0.03
– 0.62]). All correlations between intake and plasma AR levels were only significant
when comparing intakes and AR measures from the same testing period. Reported
whole-grain intakes and AR measures from different periods did not show any
significant associations. However, AR measures from both periods were significantly
correlated with whole-grain intake when it was averaged across both periods.
These results show that fasting plasma AR levels have high reproducibility
over a period of days and moderate reproducibility over a period of months. They also
confirm that non-fasting AR levels should not be used as an indicator of habitual
intake because they are greatly influenced by recent intake. This study was conducted
in Sweden where the general population consumes relatively high amounts of wholegrains and rye. The average total fiber intake in the study population was 30±14 g/day,
the average cereal fiber intake was 11±12 g/day and the average whole-grain rye
intake was 29±27 g/day. This may affect the generalizability of these results due to the
fact that other research has suggested that plasma AR levels are a more effective
biomarker at higher whole-grain intake levels (12, 85).
In 2009 Ross et al. (86) used a novel whole-grain focused FFQ to test the
associations between self-reported whole-grain intake and plasma AR levels in a freeliving population. Participants (N=33) were recruited from the area surrounding
Lausanne, Switzerland and were 58% female with an average age of 38±12 years and
an average BMI of 23±3 kg/m2. Participants completed a 43 item whole-grain focused
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FFQ on days 1 (FFQ1) and 14 (FFQ2), and a 3 day weighed food record sometime in
between. Upon completion of the 3 day weighed food record participants provided a
fasting blood sample for AR analysis.
Measures of total whole-grain intake as measured by the weighed 3 day food
record and both rounds of the FFQ were significantly correlated (r = 0.72, 0.81
respectively). All three measures of total whole-grain intake were also significantly
correlated with plasma AR levels (r = 0.57 3 day record (figure), 0.54 FFQ1, 0.55
FFQ2). In attempting to create a quantifiable model of whole-grain intake using
plasma AR levels, researchers found that AR levels could only distinguish between
low (<16g/day) and moderate/high (>29 g/day) whole-grain consumers. The study was
not powered to conduct gender-specific analyses.
These results in free-living populations highlight two major points about the
use of ARs. First, both controlled and free-living studies have shown that plasma ARs
are a more effective biomarker in individuals with higher whole-grain intakes (12, 59,
85).

Figure 9 Correlation between whole-grain intake and log total plasma AR. Whole-grain intake assessed
by 3d weighted food record. Shading indicates tertiles.
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Many of these studies (60, 61, 85-89) were conducted in Nordic populations that
consume more whole-grains than US populations; Americans consume an average of
0.97 oz servings of whole-grains per day (90), while observational studies
investigating ARs in Nordic populations have reported average intakes of 4-8 oz
servings per day (60, 87, 91, 92). This may be positively biasing the overall body of
research. Second, plasma AR levels are influenced by factors other than whole-grain
intake. The most prominent factors seem to be plasma lipid levels (specifically
triglycerides) and gender, although it has been proposed that gender-specific
differences in plasma lipids are responsible for the gender effect (12).
Diet-Disease Relationships
One of the major goals in developing dietary intake biomarkers is to make
more accurate and statistically powerful assessments of diet-disease relationships by
eliminating some of the error that is inherent in self-reported dietary data. It is
expected that a good whole-grain intake biomarker would strengthen the diet-disease
relationships seen in epidemiologic studies. However, only a limited number of studies
have looked at the associations between plasma AR concentrations and
cardiometabolic risk factors (18, 19, 93)
In 2012 Ma et al. (19) examined the relationships between self-reported wholegrain intake, plasma AR levels and cardiometabolic risk factors in older adults. The
study was an ancillary analysis on data from a vitamin K supplementation intervention
trial. Participants (N=407) were 66% female with an average age of 68±6 years and a
median BMI of 27 kg/m2. Dietary intake was assessed using the Harvard
semiquantitative 126 item FFQ which was completed at baseline and at 1 year. Fasting
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blood samples used for AR analyses were taken at 6 months. Plasma AR concentration
was significantly associated with both whole-grain rich food and bran intake (rs =
0.31, 0.27 respectively). There were no significant associations between plasma AR
concentrations and BMI, fasting blood glucose or insulin. After adjusting for age, sex,
energy intake, physical activity, smoking status, alcohol intake, vegetable intake and
fruit intake, one-way ANOVA showed a significant decrease in BMI across plasma
AR quartiles (p trend = 0.04). Although the highest plasma AR quartile had a
significantly lower average BMI than the lowest plasma AR quartile, the two groups
differed by less than 1 kg/m2 (26.7 vs 27.6 kg/m2).
In 2014 Magnustdottir et al. (18) looked at associations between plasma AR
concentration and glucose and insulin homeostasis by performing a subanalysis on
data from the SYSDIET Study (94). The SYSDIET Study was a randomized
controlled dietary intervention in nondiabetic participants with metabolic syndrome
conducted in six centers across Denmark, Sweden, Finland and Iceland. It examined
the effects of an 18 week Nordic Diet intervention which included ≥25% of energy
from whole-grains of which at least 50% were rye, barley or oats. Participants in the
Nordic diet group (N=96) received whole-grain products including oats, barley, rye
crisp bread and whole-grain wheat and rye bread. Participants in the control group
(N=70) received refined grain versions of similar products. Diet intake was assessed
from multiple four day food records kept every 1-2 weeks throughout the study and
checked by dietitians for completeness and accuracy. Biochemical measures were
taken at baseline, week 12 and week 24 and included blood lipids, fasting glucose and
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insulin. Participants also underwent an oral glucose tolerance test (OGTT) at the same
timepoints.
There were no significant associations observed between total plasma AR or
any individual homologues and fasting blood glucose, insulin or indices of insulin
sensitivity. The C17:0/C21:0 was significantly inversely associated with fasting
insulin and also significantly positively associated with the Matsuda ISI and DI
indicies of insulin sensitivity in covariate-adjusted models.
In another 2014 study Magnusdottir et al. (93) looked at associations between
plasma AR concentrations and blood lipid outcomes in the same SYSDIET study
population. Total plasma AR concentration was not significantly associated with any
blood lipid measures (LDL-C, HDL-C, LDL-C/HDL-C ratio, TAG, apolipoprotein A1
or apolipoprotein B) after adjusting for confounders. The C17:0/C21:0 ratio was
significantly inversely associated with LDL-C, LDL-C/HDL-C ratio, non-HDL-C,
TAG and apolipoprotein B, and significantly positively associated with HDL-C in
covariate adjusted models. Most of these associations were lost when a Bonferroni
correction for multiple testing was applied and only HDL-C and TAG were robust to
the correction.
These results show weak associations between plasma AR concentrations and
the C17:0/C21:0 ratio and cardiometabolic risk factors. Most of the significant models
relied heavily on confounding adjustments and, although the associations were
significant, most of the achieved effect sizes were small. However, these three studies
were all done in older adults with notable cardiometabolic risk. Over 90% of the
participants in the SYSDIET studies (18, 93) had metabolic syndrome and in the study
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by Ma et al. (19) over 70% of participants were overweight or obese. These results
warrant further study in younger, healthier populations.
Conclusion
The research presented provides strong evidence supporting the use of plasma
AR concentration as a concentration biomarker of whole-grain intake. Experimental
and observational studies have shown that ARs are valid (71, 89), reproducible (60,
95) and dose-responsive (59). Although ARs meet these broad criteria, research has
also shown that interindividual variability makes using ARs for precise predictive
modeling nearly impossible (12). This implies that ARs may be best used as broader
indicators of overall whole-grain intake, or predictors of membership in a whole-grain
intake group.
A number of unanswered questions remain in AR research. The first is whether
ARs perform equally well across a range of whole-grain intakes. The majority of
research done (60, 61, 85-89) was conducted in Nordic populations that consume
relatively high amounts of whole-grains. To confirm that ARs are a universally valid
biomarker, more validation needs to be done in populations that consume few wholegrains, primarily from wheat. The second unanswered question is whether ARs can
strengthen the diet-disease relationships seen with whole-grains in epidemiologic
studies (1, 2, 35). If ARs are a valid biomarker it is expected that they will inversely
correlate with a number of cardiometabolic risk factors. Limited research has focused
on this question, and the studies that have been done have used samples of older,
unhealthy adults (18, 19, 93). More research is needed in these two areas to further
validate and strengthen ARs as whole-grain intake biomarkers.
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Table 1 Experimental and observational studies validating plasma AR concentration as a whole-grain intake
biomarker
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